Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency

Ana Rey-Rico, Jagadeesh K. Venkatesan, Janina Frisch, Gertrud Schmitt, Amália Monge-Marcet, Patricia Lopez-Chicon, Alvaro Mata, Carlos Semino, Henning Madry, Magali Cucchiarini

Research output: Indexed journal article Articlepeer-review

46 Citations (Scopus)

Abstract

Controlling the release of recombinant adeno-associated virus (rAAV) vectors from biocompatible materials is a novel, attractive approach to increase the residence time and effectiveness of a gene carrier at a defined target site. Self-assembling peptides have an ability to form stable hydrogels and encapsulate cells upon exposure to physiological pH and ionic strength. Here, we examined the capacity of the peptide hydrogel RAD16-I in a pure (RAD) form or combined with hyaluronic acid (RAD-HA) to release rAAV vectors as a means to genetically modify primary human bone marrow-derived mesenchymal stem cells (hMSCs), a potent source of cells for regenerative medicine. Specifically, we demonstrate the ability of the systems to efficiently encapsulate and release rAAV vectors in a sustained, controlled manner for the effective transduction of hMSCs (up to 80%) without deleterious effects on cell viability (up to 100%) or on their potential for chondrogenic differentiation over time (up to 21 days). The present study demonstrates that RAD16-I is an advantageous material with tunable properties to control the release of rAAV vectors as a promising tool to develop new, improved therapeutic approaches for tissue engineering in vivo.

Original languageEnglish
Pages (from-to)118-127
Number of pages10
JournalActa Biomaterialia
Volume18
DOIs
Publication statusPublished - 1 May 2015

Keywords

  • Differentiation potency
  • Human MSCs
  • Self-assembling hydrogels
  • rAAV gene transfer

Fingerprint

Dive into the research topics of 'Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency'. Together they form a unique fingerprint.

Cite this